Index by Author

January/February 2014; Volume 68,Issue 1

  1. Lee, Sang Bong

    1. Role of Risk Assessments in Viral Safety: An FDA Perspective
      Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson and Patrick Swann
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 6-10; DOI: https://doi.org/10.5731/pdajpst.2014.00959

  2. Levy, Rich

    1. Proceedings of the 2011 Viral Clearance Symposium (South San Francisco, CA)
      Kurt Brorson and Rich Levy
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 1; DOI: https://doi.org/10.5731/pdajpst.2014.00957

  3. Miesegaes, G.

    1. Conference Summary: Gaps, Lessons Learned, and Areas for Improvement
      K. Brorson, G. Miesegaes, O. Tounekti, J. Skene and J. Blumel
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 83-89; DOI: https://doi.org/10.5731/pdajpst.2014.00968

  4. Miesegaes, George

    1. Viral Clearance by Traditional Operations With Significant Knowledge Gaps (Session II): Cation Exchange Chromatography (CEX) and Detergent Inactivation
      George Miesegaes
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 30-37; DOI: https://doi.org/10.5731/pdajpst.2014.00964

  5. Roush, David

    1. Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Anion Exchange Chromatography (AEX)
      David Roush
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 23-29; DOI: https://doi.org/10.5731/pdajpst.2014.00963
    2. Emerging Unit Operations (Session III): Hydroxyapatite, Mixed-Mode, and Adsorptive Membrane Chromatography; UV-C Inactivation; Chemical Precipitation
      Brian Hubbard and David Roush
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 51-65; DOI: https://doi.org/10.5731/pdajpst.2014.00966

  6. Skene, J.

    1. Conference Summary: Gaps, Lessons Learned, and Areas for Improvement
      K. Brorson, G. Miesegaes, O. Tounekti, J. Skene and J. Blumel
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 83-89; DOI: https://doi.org/10.5731/pdajpst.2014.00968

  7. Swann, Patrick

    1. Role of Risk Assessments in Viral Safety: An FDA Perspective
      Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson and Patrick Swann
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 6-10; DOI: https://doi.org/10.5731/pdajpst.2014.00959

  8. Tounekti, O.

    1. Conference Summary: Gaps, Lessons Learned, and Areas for Improvement
      K. Brorson, G. Miesegaes, O. Tounekti, J. Skene and J. Blumel
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 83-89; DOI: https://doi.org/10.5731/pdajpst.2014.00968

  9. Vacante, Dominick

    1. Protocol for Evaluation of Virus Inactivation Using Low-pH Treatment
      Dominick Vacante and Lisa Connell-Crowley
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 90-97; DOI: https://doi.org/10.5731/pdajpst.2014.00969

  10. Willkommen, Hannelore

    1. Viral Clearance Integration (Session IV): General Trends, Bracketing, QbD, Virus Preparation Quality Attributes
      Hannelore Willkommen
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 66-82; DOI: https://doi.org/10.5731/pdajpst.2014.00967
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In This Issue